株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腹部大動脈ステントグラフト:医療機器のパイプライン分析

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 374725
出版日 ページ情報 英文 145 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
腹部大動脈ステントグラフト:医療機器のパイプライン分析 Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2017
出版日: 2017年08月01日 ページ情報: 英文 145 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発中の腹部大動脈ステントグラフトのパイプライン製品情報について分析し、治験/製品開発の全体的な進行状況や、段階別・地域別・分野別の詳細動向、企業別・製品別の詳細情報 (治験の進行段階、開始/終了時期、認証見通しなど)、昨今の製品開発・資本取引の動きなどを盛り込んでお届けいたします。

第1章 目次

第2章 イントロダクション

  • 腹部大動脈ステントグラフトの概要

第3章 開発中の製品

  • パイプライン製品:開発段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:認証時期別 (推定)
  • 現在進行中の治験

第4章 腹部大動脈ステントグラフト:開発中のパイプライン製品 (企業別)

  • 腹部大動脈ステントグラフトの開発企業:パイプライン製品 (開発段階別)
  • 腹部大動脈ステントグラフト:開発段階別のパイプライン製品の一覧

第5章 腹部大動脈ステントグラフトの開発企業・製品の概要

  • BiFlow Medical Ltd
    • パイプライン製品および進行中の治験の概要
  • Bolton Medical, Inc.
  • Cardiatis SA
  • Cardiovate
  • Cook Medical Incorporated
  • Cordis Corporation
  • Cytograft Tissue Engineering, Inc.
  • Endologix, Inc.
  • Endoluminal Sciences Pty Ltd.
  • EndoSpan Ltd
  • Lombard Medical Technologies Inc.
  • Lombard Medical Technologies Limited
  • Medtronic plc
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • TriVascular, Inc.
  • University of Limerick
  • Venus MedTech
  • W. L. Gore & Associates, Inc.

第6章 腹部大動脈ステントグラフト:昨今の市場動向 (全72件)

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0392EPD

GlobalData's Medical Devices sector report, "Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2017" provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Abdominal Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Abdominal Aortic Stent Grafts Overview 9

3 Products under Development 10

  • 3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
  • 3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
  • 3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 12
  • 3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 13
  • 3.5 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 14

4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies 15

  • 4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 15
  • 4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 16

5 Abdominal Aortic Stent Grafts Companies and Product Overview 18

  • 5.1 BiFlow Medical Ltd Company Overview 18
    • 5.1.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Bolton Medical Inc Company Overview 19
    • 5.2.1 Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.3 Cardiatis SA Company Overview 24
    • 5.3.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.4 Cardiovate Company Overview 25
    • 5.4.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.5 Cook Medical Inc Company Overview 26
    • 5.5.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.6 Cordis Corp Company Overview 30
    • 5.6.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 33
    • 5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.8 Endologix, Inc. Company Overview 34
    • 5.8.1 Endologix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.9 Endoluminal Sciences Pty Ltd. Company Overview 45
    • 5.9.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.10 EndoSpan Ltd Company Overview 46
    • 5.10.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.11 Lombard Medical Technologies Inc. Company Overview 51
    • 5.11.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.12 Lombard Medical Technologies Ltd Company Overview 56
    • 5.12.1 Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.13 Medtronic plc Company Overview 60
    • 5.13.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.14 MicroPort Scientific Corp Company Overview 64
    • 5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.15 St. Jude Medical LLC Company Overview 65
    • 5.15.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.16 TriVascular Inc Company Overview 66
    • 5.16.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.17 University of Colorado Denver Company Overview 71
    • 5.17.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.18 University of Limerick Company Overview 72
    • 5.18.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.19 Vascutek Ltd Company Overview 73
    • 5.19.1 Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.20 Venus MedTech Company Overview 76
    • 5.20.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.21 W. L. Gore & Associates Inc Company Overview 77
    • 5.21.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 77

6 Abdominal Aortic Stent Grafts- Recent Developments 80

  • 6.1 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 80
  • 6.2 Jul 07, 2017: MPSC New COO Glendy Wang on Board 80
  • 6.3 Jun 03, 2017: Endologix Presents Positive Two-Year Clinical Data from the Nellix EVAS FORWARD IDE Trial 80
  • 6.4 May 31, 2017: Endologix Reports Positive Clinical Data from the Ovation LUCY Study 81
  • 6.5 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 82
  • 6.6 May 19, 2017: Vizient Submits Comments to the FDA about Biosimilar Interchangeability, Looks Forward to Working toward Lowering Drug Costs 85
  • 6.7 May 17, 2017: Endologix Provides an Update on the Nellix Endovascular Aneurysm Sealing System U.S. Regulatory Status 85
  • 6.8 May 15, 2017: Lombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura Stent Graft System 86
  • 6.9 May 04, 2017: Lombard Medical's Announces Data on Altura Endograft System at Scientific Sessions of the 39th Annual Charing Cross International Symposium 86
  • 6.10 May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 87
  • 6.11 Apr 26, 2017: Five-Year Data from the Medtronic ENGAGE Registry Demonstrate Durable, Consistent, and Proven Outcomes in Real-World Setting 88
  • 6.12 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 89
  • 6.13 Apr 24, 2017: Endologix to Host an Investor Conference Call to Discuss its Nellix Endovascular Aneurysm Sealing System Presentation at the Society of Vascular Surgery Annual Meeting on June 3, 2017 90
  • 6.14 Apr 20, 2017: Data Highlight Medtronic Vascular Innovations at Charing Cross 2017 90
  • 6.15 Apr 20, 2017: Lombard Medical Appoints New CEO 92
  • 6.16 Apr 18, 2017: Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results 93
  • 6.17 Apr 18, 2017: Lombard Medical's CEO Steps Down 94
  • 6.18 Apr 10, 2017: Minos Ultra Low-Profile AAA Stent-Graft System Gains CFDA Green-Path 94
  • 6.19 Mar 31, 2017: Endologix Announces Enrollment of First Patients in ELEVATE IDE Clinical Study 95
  • 6.20 Mar 30, 2017: MPSC Announces 2016 Annual Results 95
  • 6.21 Mar 28, 2017: Genesis Automation Awarded Group Purchasing Contract with Vizient To Provide Integrated Supply Chain Management Technology 97
  • 6.22 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 97
  • 6.23 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 98
  • 6.24 Feb 22, 2017: Endologix Reports Results for the Fourth Quarter and Full Year 2016 99
  • 6.25 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 100
  • 6.26 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 103
  • 6.27 Feb 14, 2017: Endologix Completes Patient Enrollment in the Ovation LUCY Study 103
  • 6.28 Feb 09, 2017: Getinge Group Awarded Three-Year Contract from Vizient for Extensive Portfolio of Peripheral Vascular Products 104
  • 6.29 Feb 09, 2017: Terumo Announces Change of Executive Officers 105
  • 6.30 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 106
  • 6.31 Feb 06, 2017: Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board 107
  • 6.32 Jan 31, 2017: Terumo Opens a Branch in Yangon 107
  • 6.33 Jan 25, 2017: Endologix Announces Reinstatement of CE Mark for AFX Endovascular AAA System 107
  • 6.34 Jan 25, 2017: Endologix Announces Reinstatement of CE Mark for AFX2 Endovascular AAA System 108
  • 6.35 Jan 24, 2017: Mayo Clinic Selects Vizient as Its Performance Improvement Partner 108
  • 6.36 Jan 17, 2017: Endologix Resumes Shipments of All Sizes of AFX2 Endovascular AAA Systems 108
  • 6.37 Jan 16, 2017: Hercules Stent Graft and Delivery System of MicroPort Endovascular Awarded 2016 Shanghai Top-Brand Product 109
  • 6.38 Dec 30, 2016: Endologix Provides Physicians with Updated Information about the AFX Endovascular AAA System 110
  • 6.39 Dec 27, 2016: Endologix Announces Temporary Hold on AFX to Resolve a Manufacturing Issue 110
  • 6.40 Dec 13, 2016: Endologix Provides Update on AFX System 111
  • 6.41 Dec 13, 2016: Endologix Provides Update on AFX2 System 111
  • 6.42 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 111
  • 6.43 Dec 06, 2016: Medtronic's Endurant II/IIs Stent Graft System Receives CE Mark for Use with ChEVAR Parallel Graft Technique 112
  • 6.44 Dec 05, 2016: Positive Long-Term Data for Lombard Medical's Aorfix Endovascular Stent Graft System Confirms Sustained Performance in the Most Challenging Anatomies 113
  • 6.45 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 114
  • 6.46 Nov 21, 2016: Multi-Centre Early Experience and Data Presented on Lombard Medical's Altura Endovascular Stent Graft at the 43rd Annual VEITHsymposium 117
  • 6.47 Nov 17, 2016: Nellix EndoVascular Aneurysm Sealing System 118
  • 6.48 Nov 17, 2016: Positive Two-Year Data from the Nellix EVAS FORWARD Global Registry Presented at 2016 VEITH Symposium 118
  • 6.49 Nov 16, 2016: Endologix Provides Update on Nellix PMA Process 119
  • 6.50 Nov 16, 2016: Positive Five-Year Results from the Global Ovation Pivotal Trial Presented at 2016 VEITH Symposium 119
  • 6.51 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 120
  • 6.52 Nov 15, 2016: Medtronic's Endurant II/IIs Stent Graft System Delivers Positive Outcomes in Patients with Challenging Aortic Aneurysms 121
  • 6.53 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 122
  • 6.54 Nov 14, 2016: Lombard Medical Announces Scientific Presentation on Aorfix Endovascular Stent Graft at the 43nd Annual VEITHsymposium 122
  • 6.55 Nov 14, 2016: Lombard Medical Announces Scientific Presentation on Altura Endovascular Stent Graft at the 43nd Annual VEITHsymposium 123
  • 6.56 Nov 01, 2016: Endologix Reports Results for the Third Quarter 2016 124
  • 6.57 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 125
  • 6.58 Oct 25, 2016: Endologix Appoints Matthew Thompson, M.D., as Chief Medical Officer 126
  • 6.59 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 127
  • 6.60 Sep 28, 2016: Vizient Launches Ediom, a Cognitive Computing and Data Science Company 128
  • 6.61 Sep 20, 2016: Endologix Reports Positive Clinical Data from Ovation LIFE (Least Invasive Fast-Track EVAR) Study 129
  • 6.62 Sep 18, 2016: MicroPort Endovascular Minos Ultra Low Profile AAA Stent-Graft Completes Patient Enrollment of Pre-market Clinical Trials 130
  • 6.63 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 130
  • 6.64 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 131
  • 6.65 Aug 30, 2016: MPSC Announces 2016 Interim Results 132
  • 6.66 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 133
  • 6.67 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2 136
  • 6.68 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2 137
  • 6.69 Aug 22, 2016: Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives 137
  • 6.70 Aug 17, 2016: Endologix Announces First Patients Treated with Ovation Alto Abdominal Stent Graft System 139
  • 6.71 Aug 02, 2016: Endologix Reports Results for the Second Quarter 2016 140

7 Appendix 142

  • 7.1 Methodology 142
  • 7.2 About GlobalData 145
  • 7.3 Contact Us 145
  • 7.4 Disclaimer 145

List of Tables

1.1 List of Tables

  • Table 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
  • Table 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
  • Table 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 12
  • Table 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 13
  • Table 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 14
  • Table 6: Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 15
  • Table 7: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 16
  • Table 8: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 9: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status 18
  • Table 10: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description 18
  • Table 11: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 12: Relay Abdominal Stent Graft - Product Status 19
  • Table 13: Relay Abdominal Stent Graft - Product Description 19
  • Table 14: Relay NBS Abdominal Stent Graft - Product Status 20
  • Table 15: Relay NBS Abdominal Stent Graft - Product Description 20
  • Table 16: Treovance Abdominal Stent Graft With Navitel Delivery System - Product Status 20
  • Table 17: Treovance Abdominal Stent Graft With Navitel Delivery System - Product Description 21
  • Table 18: Bolton Medical Inc - Ongoing Clinical Trials Overview 22
  • Table 19: Treovance Abdominal Stent Graft With Navitel Delivery System - A Phase II Clinical Study of the Safety and Performance of the Treovance Stent-graft with Navitel Delivery System for Patients with Infrarenal Abdominal Aortic Aneurysms 23
  • Table 20: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 21: Cardiatis C5 - Product Status 24
  • Table 22: Cardiatis C5 - Product Description 24
  • Table 23: Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 24: NeoVessel Vascular Graft - Product Status 25
  • Table 25: NeoVessel Vascular Graft - Product Description 25
  • Table 26: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 27: Zenith p-Branch - Product Status 26
  • Table 28: Zenith p-Branch - Product Description 26
  • Table 29: Cook Medical Inc - Ongoing Clinical Trials Overview 27
  • Table 30: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts 28
  • Table 31: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion 28
  • Table 32: Zenith p-Branch - Zenith p-Branch Multi-center Study 28
  • Table 33: Zenith p-Branch - Zenith p-Branch Pivotal Study 29
  • Table 34: Zenith p-Branch - Zenith p-Branch: Single-center Study 29
  • Table 35: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 36: INCRAFT AAA Stent Graft - Product Status 30
  • Table 37: INCRAFT AAA Stent Graft - Product Description 30
  • Table 38: Cordis Corp - Ongoing Clinical Trials Overview 31
  • Table 39: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms: INSPIRATION 32
  • Table 40: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms 32
  • Table 41: INCRAFT AAA Stent Graft - Compassionate Use of the Incraft AAA Stent Graft System 32
  • Table 42: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 43: LifeJacket AAA Stent Graft - Product Status 33
  • Table 44: LifeJacket AAA Stent Graft - Product Description 33
  • Table 45: Endologix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 46: AFX2 Bifurcated Endograft System - Product Status 34
  • Table 47: AFX2 Bifurcated Endograft System - Product Description 35
  • Table 48: AFX3 - Product Status 35
  • Table 49: AFX3 - Product Description 35
  • Table 50: AFX4 - Product Status 36
  • Table 51: AFX4 - Product Description 36
  • Table 52: Nellix CHEVAS - Product Status 36
  • Table 53: Nellix CHEVAS - Product Description 37
  • Table 54: Nellix EVAS System - Product Status 37
  • Table 55: Nellix EVAS System - Product Description 37
  • Table 56: Nellix With Snorkels - Product Status 38
  • Table 57: Nellix With Snorkels - Product Description 38
  • Table 58: Nellix2 AAA Endovascular System - Product Status 38
  • Table 59: Nellix2 AAA Endovascular System - Product Description 39
  • Table 60: Paravisceral System - Product Status 39
  • Table 61: Paravisceral System - Product Description 39
  • Table 62: Ventana 2 - Product Status 40
  • Table 63: Ventana 2 - Product Description 40
  • Table 64: Xpand BX Covered Stent - Product Status 40
  • Table 65: Xpand BX Covered Stent - Product Description 41
  • Table 66: Endologix, Inc. - Ongoing Clinical Trials Overview 42
  • Table 67: Nellix EVAS System - Aneurysm Study for Complex AAA: Evaluation of Nellix Durability 43
  • Table 68: Nellix EVAS System - Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 43
  • Table 69: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study 43
  • Table 70: Nellix EVAS System - Study of a Sealing Type Stent-graft For Abdominal Aortic Aneurysm 44
  • Table 71: Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 72: Stent-Graft With Adhesive Delivery Platform - Product Status 45
  • Table 73: Stent-Graft With Adhesive Delivery Platform - Product Description 45
  • Table 74: EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 75: Horizon AAA Repair System - Product Status 46
  • Table 76: Horizon AAA Repair System - Product Description 46
  • Table 77: Nexus - Product Status 47
  • Table 78: Nexus - Product Description 47
  • Table 79: EndoSpan Ltd - Ongoing Clinical Trials Overview 48
  • Table 80: Nexus - A Multi-center Prospective Open-label Non-randomized Clinical Study to Evaluate the Safety and Performance of the Single Branch Nexus Aortic Arch Stent Graft System 49
  • Table 81: Nexus - Feasibility Clinical Study to Evaluate the Safety and Performance of the NEXUS Aortic Arch Stent Graft System 49
  • Table 82: Horizon AAA Repair System - A Prospective Open-label Non-randomized Pivotal Study to Evaluate the Safety and Performance of the Horizon Abdominal Aortic Aneurysm (AAA) Stent Graft System 50
  • Table 83: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 84: Altura Endograft System - Product Status 51
  • Table 85: Altura Endograft System - Product Description 51
  • Table 86: FEVAR - Product Status 52
  • Table 87: FEVAR - Product Description 52
  • Table 88: Lombard Medical Technologies Inc. - Ongoing Clinical Trials Overview 53
  • Table 89: Altura Endograft System - Advantages and Limitations of Lombard's Altura Endograft Device to Simplify EVAR Procedures: A Multicenter Study 54
  • Table 90: Altura Endograft System - Altura Impact on the Treatment of Abdominal Aortic Aneurysms Using a Novel D-stent EVAR Design 54
  • Table 91: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion (ELEVATEInternational) 54
  • Table 92: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms 55
  • Table 93: Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 94: Aorfix Flexible Stent Graft System - Product Status 56
  • Table 95: Aorfix Flexible Stent Graft System - Product Description 56
  • Table 96: Low Profile Stent Graft - Product Status 57
  • Table 97: Low Profile Stent Graft - Product Description 57
  • Table 98: Lombard Medical Technologies Ltd - Ongoing Clinical Trials Overview 58
  • Table 99: Aorfix Flexible Stent Graft System - AAA Registry: Clinical Outcomes of Highly Angulated Anatomy Treated with the Aorfix Stent Graft (ARCHYTAS) 59
  • Table 100: Aorfix Flexible Stent Graft System - Aorfix Generation IV Delivery System "IntelliFlex" Study 59
  • Table 101: Aorfix Flexible Stent Graft System - Post-marketing Surveillance Program of Aorfix Endovascular Stent Graft 59
  • Table 102: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 103: Endurant Evo AAA Stent Graft System - Product Status 60
  • Table 104: Endurant Evo AAA Stent Graft System - Product Description 61
  • Table 105: Medtronic plc - Ongoing Clinical Trials Overview 62
  • Table 106: Endurant Evo AAA Stent Graft System - Endurant Evo International Clinical Trial 63
  • Table 107: Endurant Evo AAA Stent Graft System - Endurant Evo US Clinical Trial 63
  • Table 108: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 109: Minos Ultra Low Profile Abdominal Aortic Aneurysm Stent-Graft System - Product Status 64
  • Table 110: Minos Ultra Low Profile Abdominal Aortic Aneurysm Stent-Graft System - Product Description 64
  • Table 111: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 112: Amplatzer AAA Vascular Graft - Product Status 65
  • Table 113: Amplatzer AAA Vascular Graft - Product Description 65
  • Table 114: TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 115: Ovation Alto System - Product Status 66
  • Table 116: Ovation Alto System - Product Description 66
  • Table 117: Ovation Prime Abdominal Stent Graft System - Product Status 67
  • Table 118: Ovation Prime Abdominal Stent Graft System - Product Description 67
  • Table 119: TriVascular Inc - Ongoing Clinical Trials Overview 68
  • Table 120: Ovation Prime Abdominal Stent Graft System - A Post-Market Approved (PMA) Post-Approval Study to Evaluate the Long-Term Safety and Effectiveness of the Ovation/Ovation Prime Abdominal Stent Graft System 69
  • Table 121: Ovation Prime Abdominal Stent Graft System - Least Invasive Fast-Track EVAR with the Ovation Prime Abdominal Stent Graft System: TriVascular Canadian LIFE Study 69
  • Table 122: Ovation Prime Abdominal Stent Graft System - TriVascular Evaluation of Females Who are Underrepresented Candidates for Abdominal Aortic Aneurysm Repair: The LUCY Study 69
  • Table 123: Ovation Alto System - Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft IDE Study 70
  • Table 124: University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 125: Shape Memory Polymer Arterial Stent - Product Status 71
  • Table 126: Shape Memory Polymer Arterial Stent - Product Description 71
  • Table 127: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 128: Cardiovascular Graft - Product Status 72
  • Table 129: Cardiovascular Graft - Product Description 72
  • Table 130: Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 131: Next Generation Anaconda LP Stent Graft - Product Status 73
  • Table 132: Next Generation Anaconda LP Stent Graft - Product Description 73
  • Table 133: Vascutek Ltd - Ongoing Clinical Trials Overview 74
  • Table 134: Next Generation Anaconda LP Stent Graft - A Prospective, Global, Multicenter, Real World Outcome Study of Fenestrated Endovascular Aneurysm Repair Using the Fenestrated Anaconda Device 75
  • Table 135: Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 136: Tumbao EndoVascular Aortic Repair System - Product Status 76
  • Table 137: Tumbao EndoVascular Aortic Repair System - Product Description 76
  • Table 138: W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 139: GORE EXCLUDER Conformable AAA Endoprosthesis - Product Status 77
  • Table 140: GORE EXCLUDER Conformable AAA Endoprosthesis - Product Description 77
  • Table 141: W. L. Gore & Associates Inc - Ongoing Clinical Trials Overview 78
  • Table 142: GORE EXCLUDER Conformable AAA Endoprosthesis - Assessment of the GORE EXCLUDER Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms 79
  • Table 143: Glossary 144

List of Figures

1.2 List of Figures

  • Figure 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
  • Figure 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
  • Figure 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 12
  • Figure 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 13
  • Figure 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 14
Back to Top